Literature DB >> 10942531

Inhibition of ultraviolet B-induced AP-1 activation by theaflavins from black tea.

M Nomura1, W Y Ma, C Huang, C S Yang, G T Bowden, K Miyamoto, Z Dong.   

Abstract

Theaflavins are believed to be key active components in black tea for chemoprevention of cancer. However, the molecular mechanisms underlying the inhibitory effects of theaflavins are not clear. With the JB6 mouse epidermal cell line, we investigated the effects of theaflavins on ultraviolet (UV) B radiation-induced activator protein-1 (AP-1)-dependent transcriptional activation and compared them with (-)-epigallocatechin-3-gallate (EGCG), a major green tea polyphenol that has cancer chemopreventative activity. Theaflavins and EGCG inhibited UVB-induced AP-1 activation in a concentration-dependent manner. The inhibitory effects of theaflavins were stronger than those of EGCG. We found that theaflavins significantly inhibited activation of extracellular signal-regulated protein kinases and c-jun NH(2)-terminal kinases. Because the transcription factor AP-1 is important in the process of tumor promotion, the inhibitory effect of these polyphenols on AP-1 activation may further explain the anti-tumor promotion action of these tea constituents. Mol. Carcinog. 28:148-155, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942531

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  15 in total

1.  Transcription factors in the cellular signaling network as prime targets of chemopreventive phytochemicals.

Authors:  Young-Joon Surh
Journal:  Cancer Res Treat       Date:  2004-10-30       Impact factor: 4.679

Review 2.  Molecular and cellular targets.

Authors:  Ann M Bode; Zigang Dong
Journal:  Mol Carcinog       Date:  2006-06       Impact factor: 4.784

Review 3.  Tea polyphenols for the prevention of UVB-induced skin cancer.

Authors:  Pooja Sharma; Mary K Montes de Oca; Amena R Alkeswani; Sarah F McClees; Tanushree Das; Craig A Elmets; Farrukh Afaq
Journal:  Photodermatol Photoimmunol Photomed       Date:  2017-11-20       Impact factor: 3.135

4.  Theaflavin-3, 3'-digallate induces epidermal growth factor receptor downregulation.

Authors:  Hideya Mizuno; Yong-Yeon Cho; Feng Zhu; Wei-Ya Ma; Ann M Bode; Chung S Yang; Chi-Tang Ho; Zigang Dong
Journal:  Mol Carcinog       Date:  2006-03       Impact factor: 4.784

5.  Black tea polyphenols inhibit tumor proteasome activity.

Authors:  Taskeen Mujtaba; Q Ping Dou
Journal:  In Vivo       Date:  2012 Mar-Apr       Impact factor: 2.155

Review 6.  The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive.

Authors:  Arindam Dhar; Mathew R Young; Nancy H Colburn
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

7.  Caffeic acid, a phenolic phytochemical in coffee, directly inhibits Fyn kinase activity and UVB-induced COX-2 expression.

Authors:  Nam Joo Kang; Ki Won Lee; Bong Jik Shin; Sung Keun Jung; Mun Kyung Hwang; Ann M Bode; Yong-Seok Heo; Hyong Joo Lee; Zigang Dong
Journal:  Carcinogenesis       Date:  2008-12-10       Impact factor: 4.944

Review 8.  Keratinocyte proliferation, differentiation, and apoptosis--differential mechanisms of regulation by curcumin, EGCG and apigenin.

Authors:  Sivaprakasam Balasubramanian; Richard L Eckert
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-30       Impact factor: 4.219

9.  Fyn is a novel target of (-)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation.

Authors:  Zhiwei He; Faqing Tang; Svetlana Ermakova; Ming Li; Qing Zhao; Yong-Yeon Cho; Wei-Ya Ma; Hong-Seok Choi; Ann M Bode; Chung S Yang; Zigang Dong
Journal:  Mol Carcinog       Date:  2008-03       Impact factor: 4.784

10.  Common and distinct mechanisms of different redox-active carcinogens involved in the transformation of mouse JB6P+ cells.

Authors:  Sun Yang; Bobbye Misner; Rita Chiu; Frank L Meyskens
Journal:  Mol Carcinog       Date:  2008-07       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.